IN THE HIGH COURT OF AUSTRALIA
Office of the Registry
Sydney No S23 of 2019
B e t w e e n -
COMPTROLLER‑GENERAL OF CUSTOMS
Applicant
and
PHARM‑A‑CARE LABORATORIES PTY LTD (ACN 003 468 219)
Respondent
Application for special leave to appeal
GAGELER J
KEANE J
TRANSCRIPT OF PROCEEDINGS
AT SYDNEY ON FRIDAY, 17 MAY 2019, AT 11.14 AM
Copyright in the High Court of Australia
MS A.M. MITCHELMORE, SC: If the Court pleases, I appear with my learned friend, MR D.P. HUME, for the applicant. (instructed by Australian Government Solicitor)
MR S.B. LLOYD, SC: If it please the Court, I appear with MS J.E. TAYLOR, for the respondent. (instructed by Clayton Utz)
GAGELER J: Thank you. Mr Lloyd, you may as well stay standing.
MR LLOYD: What we say about the matter – there are, in effect, four topics that we want to address. The first issue is what I might call the “(section IV) at the end of Note 1(a)” issue. The Comptroller’s case is that the Full Court’s approach is novel, wrong and likely to have significant juridical and financial impacts. I will address each of those three things. We accept that the Full Court’s reasoning was not relied upon by us in the court below and the reason for that is because it did not lead anywhere so it does not affect the result at all, that reasoning.
GAGELER J: This is the second bracketed reference?
MR LLOYD: The second bracketed reference which the Full Court says limits the food and beverages to food and beverages in the category of section IV as opposed to food and beverages in other categories.
GAGELER J: The difficulty for the Comptroller or any revenue authority when a Full Court of the Federal Court has laid down the law is the difficulty of then needing to administer the law in accordance with the law as laid down, whether or not it has been argued and whether or not it might be debated if it came up in another case.
MR LLOYD: We accept that. The first point I wanted to make was that in this case the Comptroller only said that the food or beverages fell within two section IV headings anyway so it really was not sort of determinative of the case. That is the first point. I accept that that in itself might be enough to persuade the Court not to go ahead.
That turns then to the question of whether it is novel and whether it was wrong. The Comptroller says in paragraph 1 of the special leave application that he wants to return “to re‑instate the previously‑prevailing” position ‑ that is how they put it ‑ but they have advanced no case whatsoever that suggests that that was a previously prevailing position.
The gist of the Full Court’s decision is that the parenthetical provision at the end of the note can either inform or constrain the content of…
Keep reading for free
Create a free CaseChat account to read Comptroller-General of Customs v Pharm-A-Care Laboratories P... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2019] HCATrans 107
- Decision Date
CaseChat Overview and Summary
The Full Federal Court was required to determine whether the products in question, which were presented as powders to be mixed with water for oral consumption to treat dehydration, qualified as "medicaments" for the purposes of the Tariff Act. This involved an interpretation of the term "medicament" within the context of the Tariff Act and its Explanatory Notes, and whether the products' primary purpose and function aligned with the definition of a medicament, particularly in contrast to a food preparation.
Gageler and Keane JJ, in allowing the Comptroller's appeal, reasoned that the Explanatory Notes to Chapter 30 of the Harmonised System Nomenclature, which informed the interpretation of the Tariff Act, provided a broad definition of "medicaments" that encompassed preparations for the treatment or prevention of disease. Their Honours found that the oral rehydration salts and solutions, by virtue of their composition and intended use in restoring electrolyte and fluid balance in cases of dehydration, served a therapeutic purpose and were therefore correctly classified as medicaments under Item 3004.90.00. The court held that the primary judge had erred in focusing too narrowly on whether the products were "drugs" in a pharmaceutical sense, rather than on their broader therapeutic function as medicinal preparations. The appeal was allowed, and the matter remitted to the primary judge for further consideration.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi